เอกสารอ้างอิง
[1]. สำนักงานคณะกรรมการอาหารและยา กระทรวงสาธารณสุข. FLEMEX [Internet]. 2020 [cited 2022 November 28]. Available from: http://pertento.fda.moph.go.th.
[2]. บริษัท โอลิค (ประเทศไทย) จำกัด. Flemex ® [Patient information leaflet].
[3]. MIMs Thailand. Flemex ® [application]. [cited 2022 November 21].
[4]. Medinova AGC, inventor; OLIC (Thailand) Limited, assignee.Flemex. Thailand U1DR1A1022400004311C. 1997 January 9.
[5]. Lexicomp. Ambroxol [application]. [cited 2022 November 20].
[6]. Rogliani P, Gabriella MM, Page C, Puxeddu E, Cazzola M, Calzetta L. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research.2019;20:104.
[7]. Poole P, Sathananthan K, Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease (Review). Cochrane Database of Systematic Reviews.2019;5:CD001287.
[8]. Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A. Nebulized and oral think derivatives for pulmonary disease in cystic fibrosis. Cochran database of systematic review.2013;7:CD007168.
[9]. Elsevier. Cough, Adult [Internet]. [cited 2022 December 20]. Available at: https://elsevier.health/en-US/preview/cough-adult-pe.
[10]. Up to date. Cough in adults (The Basics)[application]. [cited 2022 December 20].